effect of ciprofol on ventricle function in children with congenital heart disease

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300070088

Enrollment

Unknown

Registered

2023-04-01

Start date

2023-04-01

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

congenital heart disease

Interventions

trial group:ciprofol

control group:propofol

Eligibility

Sex/Gender

All

Age

No minimum to 16 Years

Inclusion criteria

Inclusion criteria: children with congenital heart disease undergoing open-heart surgery

Exclusion criteria

Exclusion criteria: 1) Parents or guardians refuse participate the study or sign the informed cosent; 2) Children with other diseases (e.g., respiratory infection, congeintal diabetes mellitus); 3) Emergency surgery or children with unstable condition.

Design outcomes

Primary

Measure	Time frame
ventricular strain;	—

Secondary

Measure	Time frame
stroke volume;cardiac output;ejection fraction;	—

Countries

China

Contacts

Public ContactZhang Kan

shanghai children's medical center

649508943@qq.com+86 15002178102

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026